Skip to main content
AVNS logo

AVNS

Avanos Medical, Inc.
$24.96 -0.01 (-0.04%) At close · Jul 16
Market Cap
$1.17B
Shares
46,824,793

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David C. Pacitti $9,469,803
Michael Greiner $5,283,109
Kerr W. Holbrook $2,236,834
Mojirade A. James $2,149,595
Scott Galovan $2,039,138
Sigfrido Delgado $1,722,819
Jason Pickett $1,321,118
Warren J. Machan $405,000
Fiscal 2024
Executive Total
Michael Greiner $4,701,549
Kerr W. Holbrook $2,197,998
Mojirade A. James $1,913,221
Scott Galovan $1,073,344
Sigfrido Delgado $806,844
Jason Pickett $615,137
Warren J. Machan $332,500
Fiscal 2023
Executive Total
Michael Greiner $2,986,702
Kerr W. Holbrook $2,147,797
Mojirade A. James $1,903,852
Scott Galovan $881,210
Jason Pickett $630,280
Warren J. Machan $390,817
Fiscal 2022
Executive Total
Joseph Woody $6,872,373
Michael Greiner $2,640,411
Mojirade A. James $1,884,500
Kerr W. Holbrook $1,436,848
William D. Haydon $1,331,440
David E. Ball $1,204,279
Fiscal 2021
Executive Total
Joseph Woody $5,478,186
Michael Greiner $1,724,957
Kerr W. Holbrook $1,219,804
William D. Haydon $1,205,549
David E. Ball $857,552
Mojirade A. James
Fiscal 2020
Executive Total
Joseph Woody $7,550,729
Michael Greiner $3,240,203
John W. Wesley $2,350,705
David E. Ball $1,019,637
Arjun R. Sarker $1,003,612
William D. Haydon $537,364
Fiscal 2019
Executive Total
Joseph F $5,023,674
Joseph Woody $5,023,674
John R. Tushar $1,643,426
David E. Ball $1,044,463
John W. Wesley $940,932
Warren J $911,184
Arjun R. Sarker $696,798
Steven E $257,134
Fiscal 2018
Executive Total
Joseph Woody $6,449,263
Joseph F $6,449,263
Steven E $1,686,580
John R. Tushar $1,307,854
John W. Wesley $1,153,600
Arjun R. Sarker $1,118,933
Fiscal 2017
Executive Total
Joseph F $6,163,095
Steven E $1,974,562
John W. Wesley $1,417,125
Key facts CIK 1606498 CUSIP 05350V106 13F (30d) 25 filings 24 filers Visit website Investor relations